2 “Forever” Stocks to Grab on This Pullback (paying up to 7.7%)

Our Archive

Search completed

What if you could lock in a 7.7% gain year in and year out, and get it all in cash, no matter what the S&P 500 does?

With the market’s paper gains for 2018 now mostly gone, no thanks to the correction, I’m guessing this would have a lot of appeal. So today, I’m going to show you 2 “pullback-proof” dividends paying 5.4% and 7.7%, with plenty of price upside ahead, too.

Thanks to the pullback, these two are perfect for buying now and sitting on forever (or at least a few decades). More on them in a moment.

How to Beat Fear and Get Rich From the Pullback

First, if the daily barrage of negative headlines has you pondering bailing out on stocks, stick with me for a second, because that’s the worst thing you could do now.… Read more

Read More

We’ve seen a lot of volatility and fear in 2018, and that’s handed us a great buying opportunity—particularly in the 5 unloved funds I’ll show you below.

Make no mistake: each of these 5 despised funds is poised for serious upside before 2018 is out … and they’ll pay us 8.2% average dividends, to boot. That’s enough to hand you $3,400 a month on a $500k nest egg! Before we get to them, let’s take a look back at the year so far and see what’s handed us this terrific opportunity.

History Is Set to Repeat

If you bought closed-end funds (CEFs) back in early March, when the market tanked and I urged investors to buy, you’d be enjoying a nice double-digit total return in just 6 months:

Hated CEFs Turn the Corner

Why did these 3 funds—the Reaves Utility Income Fund (UTG), the Cohen & Steers Infrastructure Fund (UTF) and the DNP Select Income Fund (DNP)—all of which I recommended back on March 1—soar?… Read more

Read More

Today I want to show you a beaten-down sector that has a long history of crushing the market—and 4 funds that should be on your radar now.

These 4 funds are a great place to pocket dividends up to 10.9% (or $10,900 a year on a $100k investment) while you wait for the market to realize that it’s discounting their industry far too much.

I’m talking about 4 standout fund buys from the biotech sector.

Biotech has fallen over 10% from its 2018 high and is now down a bit more than the broader market. Just look at the iShares Nasdaq Biotechnology ETF (IBB) vs.…
Read more

Read More

About Author

Brett

Hi, I’m Brett Owens – and I’m a financial junkie. My “problem” started incollege, when I got a little dose of the stock market – man, was I hooked…in no time, I was reading the Wall Street Journal religously.

Sign up for our Newsletter

Categories